There is a realistic expectation that the global effort in vaccination will bring the pandemic
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) under control …

Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

Despite the success of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccines, there remains a need for more prevention and treatment options for individuals …

COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

Objectives The mRNA coronavirus disease 2019 (COVID-19) vaccines have shown high
effectiveness in the prevention of symptomatic COVID-19, hospitalization, severe disease …

Patients with kidney failure are at increased risk of SARS-CoV-2 infection, making effective
vaccinations a critical need. It is not known how well mRNA vaccines induce B and plasma …

According to preliminary data, seroconversion after mRNA SARS‐CoV‐2 vaccination might
be unsatisfactory in Kidney Transplant Recipients (KTRs). However, it is unknown if …

Abstract Background Coronavirus disease (COVID–19) has resulted in the death of more
than 3.5 million people worldwide. While COVID–19 mostly affects the lungs, different …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated
with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent …

The COVID-19 pandemic has profound adverse effects on the population on dialysis.
Patients requiring dialysis are at an increased risk of SARS-CoV-2 infection and mortality …